|
Website:
http://www.option.com
Phone: +32 16 31 74 11 |
Address:
45 Kolonel Begaultlaan
B-3012 Leuven, |
Company Description
Option NV Formerly known as Option International NV. The Company's principal activities are the design, manufacture, distribution and marketing of mobile data equipment. The Company's products include: GSM-Ready PC cards, support handsets, modems and connectivity kits. In 1999, the group was awarded the ISO 9002 certificate for its quality. The Company has offices in the following countries: Australia, the United States, Germany, France and Ireland.
Key People
| Chairman | Jan Callewaert |
| Chief Financial Officer | Frederic Convent |
Related Business Topics
Breaking News
Forbes.com - November 23, 2009 11:42 PM
AMSTERDAM, Nov 24 (Reuters) - Delta Lloyd NV says: * The Joint Global Coordinators, Goldman Sachs * The free float of Delta Lloyd shares increases from 38.3 percent to 41.1 percent * the total gross proceeds of the IPO increases to ...
Reuters - November 19, 2009 11:56 AM
WASHINGTON, Nov. 19 /PRNewswire-USNewswire/ -- Last night, Majority Leader Harry Reid (D-NV) and the Senate Democrats introduced a new Senate version of health care reform that includes government funding for elective abortion. The 'Patient Protection ...
Reuters - November 19, 2009 7:02 AM
MANHATTAN, NV, Nov 19 (MARKET WIRE) -- This Royal Standard Minerals, Inc.'s (OTCBB: RYSMF) release is directed to the Company's new investors who may not be aware of the current activities in RYSMF or the distribution of the projects that are owned or ...
Reuters - November 18, 2009 7:01 AM
AMSTERDAM, NETHERLANDS, Nov 18 (MARKET WIRE) -- AMG Advanced Metallurgical Group N.V. ('AMG', EURONEXT AMSTERDAM: 'AMG') has agreed to loan $5.0 million to Timminco's wholly-owned subsidiary, Becancour Silicon Inc. ('Becancour'), in exchange for a ...
Reuters - November 16, 2009 3:33 PM
Compounds show promise in early clinical studies WILMINGTON, N.C.--(Business Wire)-- PPD, Inc. (Nasdaq: PPDI) today announced it has entered an agreement with Janssen Pharmaceutica N.V. to develop and commercialize two Phase II-ready therapeutic ...
